1. Home
  2. KALA vs ABLV Comparison

KALA vs ABLV Comparison

Compare KALA & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALA
  • ABLV
  • Stock Information
  • Founded
  • KALA 2009
  • ABLV 2015
  • Country
  • KALA United States
  • ABLV China
  • Employees
  • KALA N/A
  • ABLV N/A
  • Industry
  • KALA Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • KALA Health Care
  • ABLV
  • Exchange
  • KALA Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • KALA 32.0M
  • ABLV 38.1M
  • IPO Year
  • KALA 2017
  • ABLV N/A
  • Fundamental
  • Price
  • KALA $6.48
  • ABLV $0.90
  • Analyst Decision
  • KALA Strong Buy
  • ABLV
  • Analyst Count
  • KALA 2
  • ABLV 0
  • Target Price
  • KALA $15.00
  • ABLV N/A
  • AVG Volume (30 Days)
  • KALA 33.2K
  • ABLV 14.7K
  • Earning Date
  • KALA 11-12-2024
  • ABLV 01-01-0001
  • Dividend Yield
  • KALA N/A
  • ABLV N/A
  • EPS Growth
  • KALA N/A
  • ABLV 18.07
  • EPS
  • KALA N/A
  • ABLV 0.24
  • Revenue
  • KALA N/A
  • ABLV $148,999,819.00
  • Revenue This Year
  • KALA N/A
  • ABLV N/A
  • Revenue Next Year
  • KALA N/A
  • ABLV N/A
  • P/E Ratio
  • KALA N/A
  • ABLV $3.59
  • Revenue Growth
  • KALA N/A
  • ABLV 2.58
  • 52 Week Low
  • KALA $4.21
  • ABLV $0.67
  • 52 Week High
  • KALA $10.97
  • ABLV $3.94
  • Technical
  • Relative Strength Index (RSI)
  • KALA 49.93
  • ABLV 42.43
  • Support Level
  • KALA $6.00
  • ABLV $0.82
  • Resistance Level
  • KALA $7.85
  • ABLV $0.93
  • Average True Range (ATR)
  • KALA 0.40
  • ABLV 0.06
  • MACD
  • KALA -0.11
  • ABLV 0.00
  • Stochastic Oscillator
  • KALA 29.19
  • ABLV 30.64

About KALA KALA BIO Inc.

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: